• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流式细胞术作为神经母细胞瘤的诊断工具。

Flow cytometry as a diagnostic tool in neuroblastoma.

机构信息

Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.

出版信息

J Immunol Methods. 2021 Nov;498:113135. doi: 10.1016/j.jim.2021.113135. Epub 2021 Aug 31.

DOI:10.1016/j.jim.2021.113135
PMID:34478717
Abstract

In recent years, there has been an expansion in the use of flow cytometry (FC) immunophenotyping in the diagnosis and monitoring of childhood solid neoplasms. Neuroblastoma (NB), in turn, is the most common extracranial solid tumor in childhood. In the present study, we sought to compare FC and anatomopathological examination (PA) / immunohistochemistry (IHC) of children diagnosed or suspected with NB. The median age was 59 months (minimum 0; maximum 325 months), of these 12 were male (57.1%, 12/21). Forty-eight samples (27 bone marrow (BM), 10 peripheral blood (PB), 8 primary tumors (PT) and 2 liver nodules (HN) and 1 rib fragment (RF)) from 21 patients were evaluated. Twenty-nine samples were from patients with clinical suspicion while 19 samples were from patients with previously confirmed diagnosis. Thirteen samples (7 BM, 5 PT and 1 HN) presented NB when analyzed in FC while 8 (3 BM and 5 PT) samples were positive for NB in the PA/IHC. They were concordant in 88.9% of the cases. No NB cells were identified in any PB. Considering the PA as the gold standard, the FC obtained a sensitivity of 100%, a specificity of 86%, a positive predictive value of 67% and a negative predictive value of 100%. This study demonstrates that FC can be used as a methodology for diagnosis and assessment of NB involvement. In addition, FC has the advantage of allowing a quick diagnosis and accurate classification of the disease, and can also assist in monitoring the treatment.

摘要

近年来,流式细胞术(FC)免疫表型分析在儿童实体瘤的诊断和监测中的应用不断扩大。神经母细胞瘤(NB)是儿童期最常见的颅外实体瘤。本研究旨在比较 FC 与解剖病理检查(PA)/免疫组织化学(IHC)在诊断或疑似 NB 儿童中的应用。中位年龄为 59 个月(最小 0;最大 325 个月),其中男性 12 例(57.1%,12/21)。对 21 例患者的 48 份样本(27 份骨髓(BM)、10 份外周血(PB)、8 份原发肿瘤(PT)、2 份肝结节(HN)和 1 份肋骨碎片(RF))进行了评估。29 份样本来自临床疑似患者,19 份样本来自已确诊患者。在 FC 分析中,13 份(7 份 BM、5 份 PT 和 1 份 HN)样本显示为 NB,而 8 份(3 份 BM 和 5 份 PT)样本在 PA/IHC 中呈 NB 阳性。这些结果在 88.9%的病例中是一致的。任何 PB 中均未发现 NB 细胞。以 PA 为金标准,FC 的敏感性为 100%,特异性为 86%,阳性预测值为 67%,阴性预测值为 100%。本研究表明,FC 可作为 NB 诊断和评估的一种方法。此外,FC 具有快速诊断和准确分类疾病的优势,还可辅助监测治疗。

相似文献

1
Flow cytometry as a diagnostic tool in neuroblastoma.流式细胞术作为神经母细胞瘤的诊断工具。
J Immunol Methods. 2021 Nov;498:113135. doi: 10.1016/j.jim.2021.113135. Epub 2021 Aug 31.
2
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.多参数流式细胞术突出 B7-H3 作为 GD2neg/low 神经母细胞瘤变异体的新型诊断/治疗靶点。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002293.
3
Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.多参数流式细胞术检测初诊骨髓疾病对神经母细胞瘤患儿的预后价值。
J Cancer Res Clin Oncol. 2019 Feb;145(2):535-542. doi: 10.1007/s00432-018-02831-w. Epub 2019 Jan 2.
4
Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.对神经母细胞瘤患者的外周血和骨髓进行肿瘤细胞的流式细胞术分析。
Cancer. 1998 Feb 1;82(3):591-9.
5
Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.联合使用多参数流式细胞术和细胞形态学以增强对骨髓中神经母细胞瘤转移细胞的检测。
Int J Lab Hematol. 2020 Feb;42(1):52-60. doi: 10.1111/ijlh.13137. Epub 2019 Dec 10.
6
[Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].[流式细胞术检测神经母细胞瘤患儿骨髓病变的预后价值]
Vopr Onkol. 2014;60(4):469-75.
7
Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens.流式细胞术与细胞形态学在积液和骨髓标本中检测神经母细胞瘤细胞的比较分析
Fetal Pediatr Pathol. 2019 Feb;38(1):1-7. doi: 10.1080/15513815.2018.1494231. Epub 2019 Jan 22.
8
Comparative Analysis of Multicolor Flow Cytometry and Immunohistochemistry for the Detection of Disseminated Tumor Cells.多色流式细胞术与免疫组织化学检测播散肿瘤细胞的比较分析
Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):305-315. doi: 10.1097/PAI.0000000000000519.
9
TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.外周血和骨髓中的TH和DCX信使核糖核酸可预测转移性神经母细胞瘤患者的预后。
J Cancer Res Clin Oncol. 2016 Mar;142(3):573-80. doi: 10.1007/s00432-015-2054-7. Epub 2015 Oct 24.
10
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.ELAVL4实时定量逆转录聚合酶链反应在检测播散性神经母细胞瘤细胞中的潜在应用。
Clin Chem. 2006 Mar;52(3):438-45. doi: 10.1373/clinchem.2005.059485. Epub 2005 Dec 29.

引用本文的文献

1
Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.高危神经母细胞瘤多模态骨髓分析对微小残留病和免疫治疗靶点的灵敏检测——一项多中心研究
J Exp Clin Cancer Res. 2025 Aug 2;44(1):224. doi: 10.1186/s13046-025-03481-w.
2
Diagnostic technologies for neuroblastoma.神经母细胞瘤的诊断技术
Lab Chip. 2025 Jul 14. doi: 10.1039/d4lc00005f.
3
Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma.
骨髓活检与流式细胞术在显示神经母细胞瘤骨髓转移中的比较
Diagnostics (Basel). 2024 Dec 11;14(24):2776. doi: 10.3390/diagnostics14242776.
4
The importance of basic and translational research in caring for children with malignant solid tumors in Latin America.基础研究与转化研究在拉丁美洲照料恶性实体瘤儿童方面的重要性。
Rev Panam Salud Publica. 2024 May 2;48:e48. doi: 10.26633/RPSP.2024.48. eCollection 2024.
5
A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and Blood.一种用于定量评估地努图希单抗与肿瘤、骨髓和血液中神经母细胞瘤细胞结合情况的多色流式细胞术检测方法。
J Clin Med. 2023 Sep 27;12(19):6223. doi: 10.3390/jcm12196223.